{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:13:05Z","timestamp":1769825585647,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"crossref","award":["VENI 14410"],"award-info":[{"award-number":["VENI 14410"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13321-019-0337-8","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T09:04:33Z","timestamp":1550135073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling"],"prefix":"10.1186","volume":"11","author":[{"given":"Lindsey","family":"Burggraaff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Oranje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Gouka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"van der Pijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Geldof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman W. T.","family":"van Vlijmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan P.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard J. P.","family":"van Westen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"337_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1079\/bjn2002763","volume":"89","author":"IS Wood","year":"2003","unstructured":"Wood IS, Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Brit J Nutr 89:3\u20139. \n                    https:\/\/doi.org\/10.1079\/bjn2002763","journal-title":"Brit J Nutr"},{"key":"337_CR2","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1021\/jm990175n","volume":"42","author":"K Tsujihara","year":"1999","unstructured":"Tsujihara K, Hongu M, Saito K et al (1999) Na+\u2009-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4\u2032-dehydroxyphlorizin derivatives substituted on the B ring. J Med Chem 42:5311\u20135324. \n                    https:\/\/doi.org\/10.1021\/jm990175n","journal-title":"J Med Chem"},{"key":"337_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1152\/physrev.00055.2009","volume":"91","author":"EM Wright","year":"2011","unstructured":"Wright EM, Loo DD, Hirayama BA (2011) Biology of human sodium glucose transporters. Physiol Rev 91:733\u2013794","journal-title":"Physiol Rev"},{"key":"337_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2337\/db11-1029","volume":"61","author":"V Gorboulev","year":"2012","unstructured":"Gorboulev V, Sch\u00fcrmann A, Vallon V et al (2012) Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61:187\u2013196. \n                    https:\/\/doi.org\/10.2337\/db11-1029","journal-title":"Diabetes"},{"key":"337_CR5","doi-asserted-by":"publisher","first-page":"e001","DOI":"10.1136\/bmjopen-2012-001007","volume":"2","author":"C Clar","year":"2012","unstructured":"Clar C, Gill JA, Court R, Waugh N (2012) Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open 2:e001\u2013e007. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2012-001007","journal-title":"BMJ Open"},{"key":"337_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/dom.12185","volume":"15","author":"J Rosenstock","year":"2013","unstructured":"Rosenstock J, Seman LJ, Jelaska A et al (2013) Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia. Diabetes Obes Metab 15:1154\u20131160. \n                    https:\/\/doi.org\/10.1111\/dom.12185","journal-title":"Diabetes Obes Metab"},{"key":"337_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/clpt.2008.250","volume":"85","author":"B Komoroski","year":"2009","unstructured":"Komoroski B, Vachharajani N, Feng Y et al (2009) Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2\u00a0weeks in patients with type 2 diabetes mellitus. Clin Pharmacol Ther 85:513\u2013519. \n                    https:\/\/doi.org\/10.1038\/clpt.2008.250","journal-title":"Clin Pharmacol Ther"},{"key":"337_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2337\/dc14-2806","volume":"38","author":"AT Sands","year":"2015","unstructured":"Sands AT, Zambrowicz BP, Rosenstock J et al (2015) Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes. Diabetes Care 38:1181\u20131188. \n                    https:\/\/doi.org\/10.2337\/dc14-2806","journal-title":"Diabetes Care"},{"key":"337_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/14656566.2017.1414801","volume":"19","author":"MS Rendell","year":"2018","unstructured":"Rendell MS (2018) Efficacy and safety of sotagliflozin in treating diabetes type 1. Expert Opin Pharmacother 19:307\u2013315. \n                    https:\/\/doi.org\/10.1080\/14656566.2017.1414801","journal-title":"Expert Opin Pharmacother"},{"key":"337_CR10","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1021\/jf9008197","volume":"57","author":"S Masumoto","year":"2009","unstructured":"Masumoto S, Akimoto Y, Oike H, Kobori M (2009) Dietary phloridzin reduces blood glucose levels and reverses SGLT1 expression in the small intestine in streptozotocin-induced diabetic mice. J Agric Food Chem 57:4651\u20134656. \n                    https:\/\/doi.org\/10.1021\/jf9008197","journal-title":"J Agric Food Chem"},{"key":"337_CR11","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00125-018-4654-7","volume":"61","author":"T Rieg","year":"2018","unstructured":"Rieg T, Vallon V (2018) Development of SGLT1 and SGLT2 inhibitors. Diabetologia 61:2079\u20132086. \n                    https:\/\/doi.org\/10.1007\/s00125-018-4654-7","journal-title":"Diabetologia"},{"key":"337_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s13300-017-0342-8","volume":"9","author":"L Spatola","year":"2018","unstructured":"Spatola L, Finazzi S, Angelini C et al (2018) SGLT1 and SGLT1 inhibitors: a role to be assessed in the current clinical practice. Diabetes Ther 9:427\u2013430. \n                    https:\/\/doi.org\/10.1007\/s13300-017-0342-8","journal-title":"Diabetes Ther"},{"key":"337_CR13","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton A, Hersey A, Nowotka M et al (2017) The ChEMBL database in 2017. Nucleic Acids Res 45:D945\u2013D954. \n                    https:\/\/doi.org\/10.1093\/nar\/gkw1074","journal-title":"Nucleic Acids Res"},{"key":"337_CR14","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento AP, Gaulton A, Hersey A et al (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res 42:D1083\u2013D1090. \n                    https:\/\/doi.org\/10.1093\/nar\/gkt1031","journal-title":"Nucleic Acids Res"},{"key":"337_CR15","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100\u2013D1107. \n                    https:\/\/doi.org\/10.1093\/nar\/gkr777","journal-title":"Nucleic Acids Res"},{"key":"337_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1039\/C0MD00165A","volume":"2","author":"GJP Westen van","year":"2011","unstructured":"van Westen GJP, Wegner JK, IJzerman AP et al (2011) Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets. Med Chem Commun 2:16\u201330. \n                    https:\/\/doi.org\/10.1039\/C0MD00165A","journal-title":"Med Chem Commun"},{"key":"337_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin L, Yee SW, Kim RB, Giacomini KM (2015) SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov 14:543\u2013560. \n                    https:\/\/doi.org\/10.1038\/nrd4626","journal-title":"Nat Rev Drug Discov"},{"key":"337_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/mol.112.084152","volume":"83","author":"T Bruyn De","year":"2013","unstructured":"De Bruyn T, van Westen GJP, IJzerman AP et al (2013) Structure-based identification of OATP1B1\/3 inhibitors. Mol Pharmacol 83:1257\u20131267","journal-title":"Mol Pharmacol"},{"key":"337_CR19","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1021\/jm3003069","volume":"55","author":"GJP Westen van","year":"2012","unstructured":"van Westen GJP, van den Hoven OO, van der Pijl R et al (2012) Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data. J Med Chem 55:7010\u20137020. \n                    https:\/\/doi.org\/10.1021\/jm3003069","journal-title":"J Med Chem"},{"key":"337_CR20","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1021\/acs.jcim.7b00338","volume":"57","author":"G Tresadern","year":"2017","unstructured":"Tresadern G, Trabanco AA, P\u00e9rez-Benito L et al (2017) Identification of allosteric modulators of metabotropic glutamate 7 receptor using proteochemometric modeling. J Chem Inf Model 57:2976\u20132985. \n                    https:\/\/doi.org\/10.1021\/acs.jcim.7b00338","journal-title":"J Chem Inf Model"},{"key":"337_CR21","doi-asserted-by":"publisher","first-page":"e27518","DOI":"10.1371\/journal.pone.0027518","volume":"6","author":"GJP Westen van","year":"2011","unstructured":"van Westen GJP, Wegner JK, Geluykens P et al (2011) Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development. PLoS ONE 6:e27518. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0027518","journal-title":"PLoS ONE"},{"key":"337_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/026119290503300508","volume":"33","author":"J Jaworska","year":"2005","unstructured":"Jaworska J, Nikolova-Jeliazkova N, Aldenberg T (2005) QSAR applicabilty domain estimation by projection of the training set descriptor space: a review. Altern Lab Anim 33:445\u2013459","journal-title":"Altern Lab Anim"},{"key":"337_CR23","unstructured":"MicroSource Discovery Systems (2015) Spectrum collection. \n                    http:\/\/www.msdiscovery.com\/spectrum.html\n                    \n                  . Accessed 25 Nov 2015"},{"key":"337_CR24","first-page":"2579","volume":"9","author":"L Maaten Van Der","year":"2008","unstructured":"Van Der Maaten L, Hinton G (2008) Visualizing data using t-SNE. J Mach Learn Res 9:2579\u20132605","journal-title":"J Mach Learn Res"},{"key":"337_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"337_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10822-015-9860-5","volume":"29","author":"G Papadatos","year":"2015","unstructured":"Papadatos G, Gaulton A, Hersey A, Overington JP (2015) Activity, assay and target data curation and quality in the ChEMBL database. J Comput Aided Mol Des 29:885\u2013896. \n                    https:\/\/doi.org\/10.1007\/s10822-015-9860-5","journal-title":"J Comput Aided Mol Des"},{"key":"337_CR27","unstructured":"Enamine (2017) Enamine HTS collection. \n                    https:\/\/enamine.net\n                    \n                  . Accessed 1 Oct 2017"},{"key":"337_CR28","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.2174\/138161212799504858","volume":"18","author":"D Charmot","year":"2012","unstructured":"Charmot D (2012) Non-systemic drugs: a critical review. Curr Pharm Des 18:1434\u20131445. \n                    https:\/\/doi.org\/10.2174\/138161212799504858","journal-title":"Curr Pharm Des"},{"key":"337_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41419-018-0273-y","volume":"9","author":"PF Secker","year":"2018","unstructured":"Secker PF, Beneke S, Schlichenmaier N et al (2018) Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect. Cell Death Dis 9:226. \n                    https:\/\/doi.org\/10.1038\/s41419-018-0273-y","journal-title":"Cell Death Dis"},{"key":"337_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1021\/acs.jmedchem.6b01541","volume":"60","author":"NC Goodwin","year":"2017","unstructured":"Goodwin NC, Ding Z-M, Harrison BA et al (2017) Discovery of LX2761, a sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor restricted to the intestinal lumen, for the treatment of diabetes. J Med Chem 60:710\u2013721. \n                    https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01541","journal-title":"J Med Chem"},{"key":"337_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1124\/jpet.117.240820","volume":"362","author":"DR Powell","year":"2017","unstructured":"Powell DR, Smith MG, Doree DD et al (2017) LX2761, a sodium\/glucose cotransporter 1 inhibitor restricted to the intestine, improves glycemic control in mice. J Pharmacol Exp Ther 362:85\u201397","journal-title":"J Pharmacol Exp Ther"},{"key":"337_CR32","doi-asserted-by":"publisher","first-page":"G887","DOI":"10.1152\/ajpgi.00068.2016","volume":"310","author":"A Lehmann","year":"2016","unstructured":"Lehmann A, Hornby PJ (2016) Intestinal SGLT1 in metabolic health and disease. Am J Physiol Liver Physiol 310:G887\u2013G898. \n                    https:\/\/doi.org\/10.1152\/ajpgi.00068.2016","journal-title":"Am J Physiol Liver Physiol"},{"key":"337_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MNH.0000000000000152","volume":"24","author":"SB Poulsen","year":"2015","unstructured":"Poulsen SB, Fenton RA, Rieg T (2015) Sodium-glucose cotransport. Curr Opin Nephrol Hypertens 24:463\u2013469. \n                    https:\/\/doi.org\/10.1097\/MNH.0000000000000152","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"337_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF00234938","volume":"142","author":"MP Lostao","year":"1994","unstructured":"Lostao MP, Hirayama BA, Loo DDF, Wright EM (1994) Phenylglucosides and the Na+\/glucose cotransporter (SGLT1): analysis of interactions. J Membr Biol 142:161\u2013170. \n                    https:\/\/doi.org\/10.1007\/BF00234938","journal-title":"J Membr Biol"},{"key":"337_CR35","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1038\/s41467-018-07700-1","volume":"9","author":"P Bisignano","year":"2018","unstructured":"Bisignano P, Ghezzi C, Jo H et al (2018) Inhibitor binding mode and allosteric regulation of Na+-glucose symporters. Nat Commun 9:5245. \n                    https:\/\/doi.org\/10.1038\/s41467-018-07700-1","journal-title":"Nat Commun"},{"key":"337_CR36","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nature09580","volume":"468","author":"A Watanabe","year":"2010","unstructured":"Watanabe A, Choe S, Chaptal V et al (2010) The mechanism of sodium and substrate release from the binding pocket of vSGLT. Nature 468:988\u2013991","journal-title":"Nature"},{"key":"337_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"J-H Zhang","year":"1999","unstructured":"Zhang J-H, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67\u201373. \n                    https:\/\/doi.org\/10.1177\/108705719900400206","journal-title":"J Biomol Screen"},{"key":"337_CR38","unstructured":"Dassault Syst\u00e8mes BIOVIA (2016) Pipeline pilot (version 2016). Biovia"},{"key":"337_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers F, Wilm A, Dineen D et al (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539","journal-title":"Mol Syst Biol"},{"key":"337_CR40","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1021\/jm9700575","volume":"41","author":"M Sandberg","year":"1998","unstructured":"Sandberg M, Eriksson L, Jonsson J et al (1998) New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J Med Chem 41:2481\u20132491. \n                    https:\/\/doi.org\/10.1021\/jm9700575","journal-title":"J Med Chem"},{"key":"337_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1758-2946-5-42","volume":"5","author":"GJP Westen van","year":"2013","unstructured":"van Westen GJP, Swier RF, Cortes-Ciriano I et al (2013) Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets. J Cheminform 5:42. \n                    https:\/\/doi.org\/10.1186\/1758-2946-5-42","journal-title":"J Cheminform"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-019-0337-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-019-0337-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-019-0337-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T19:03:51Z","timestamp":1581620631000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-019-0337-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["337"],"URL":"https:\/\/doi.org\/10.1186\/s13321-019-0337-8","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}